Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Bayer announces copromotion agreement for cerivastatin

Jan. 8, 1998

Cell Genesys to receive milestone payment from HMR for GA-EPO

Jan. 7, 1998

Spleen ultrafiltrate imparts favorable effects in chemotherapy recipients

Jan. 7, 1998

Native calcitonin mimetics from ZymoGenetics

Jan. 5, 1998

Lilly discovers potent, selective and orally active beta3 agonists for diabetes, obesity

Jan. 2, 1998

Akzo Nobel describes new gonadotropins with therapeutic potential

Jan. 2, 1998

OGT-918 clinical development program begins

Dec. 30, 1997

Pfizer discovers potent, orally active human liver glycogen phosphorylase inhibitor

Dec. 30, 1997

S-22068: effects on glucose tolerance and plasma insulin in mice

Dec. 30, 1997

Boehringer Mannheim presents new calcium regulators

Dec. 30, 1997

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...